Pasar al contenido principal

-

FPDI-2013-17134

•
Nombre agencia financiadora Ministerio de Ciencia e Innovación
Acrónimo agencia financiadora MICINN
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Formación
Convocatoria Contratos para la Formación Posdoctoral
Año convocatoria 2013
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario FUNDACION PRIVADA INSTITUT DE RECERCA SOBRE IMMUNOPATOLOGIES-CAIXA
Identificador persistente http://dx.doi.org/10.13039/501100004837

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Sensitive quantification of the HIV-1 reservoir in gut-associated lymphoid tissue

  • Morón-López, Sara
  • Puertas, Maria C.
  • Gálvez, Cristina
  • Navarro Mercadé, Jordi
  • Carrasco, Anna
  • Crespo Casal, Manuel
  • Esteve, Maria
Biòpsia; VIH-1; Teixit limfoide, Biopsia; VIH-1; Tejido linfoide, Biopsy; HIV-1; Lymphoid tissue, Background The implementation of successful strategies to achieve an HIV cure has become a priority in HIV research. However, the current location and size of HIV reservoirs is still unknown since there are limited tools to evaluate HIV latency in viral sanctuaries such as gut-associated lymphoid tissue (GALT). As reported in the so called “Boston Patients”, despite undetectable levels of proviral HIV-1 DNA in blood and GALT, viral rebound happens in just few months after ART interruption. This fact might imply that current methods are not sensitive enough to detect residual reservoirs. Showing that, it is imperative to improve the detection and quantification of HIV-1 reservoir in tissue samples. Herein, we propose a novel non-enzymatic protocol for purification of Lamina Propria Leukocytes (LPL) from gut biopsies combined to viral HIV DNA (vDNA) quantification by droplet digital PCR (ddPCR) to improve the sensitivity and accuracy of viral reservoir measurements (LPL-vDNA assay). Methods Endoscopic ileum biopsies were sampled from 12 HIV-1-infected cART-suppressed subjects. We performed a DTT/EDTA-based treatment for epithelial layer removal followed by non-enzymatic disruption of the tissue to obtain lamina propria cell suspension (LP). CD45+ cells were subsequently purified by flow sorting and vDNA was determined by ddPCR. Results vDNA quantification levels were significantly higher in purified LPLs (CD45+) than in bulk LPs (p<0.01). The levels of vDNA were higher in ileum samples than in concurrent PBMC from the same individuals (p = 0.002). As a result of the increased sensitivity of this purification method, the Poisson 95% confidence intervals of the vDNA quantification data from LPLs were narrower than that from bulk LPs. Of note, vDNA was unambiguously quantified above the detection limit in 100% of LPL samples, while only in 58% of bulk LPs. Conclusion We propose an innovative combined protocol for a more sensitive detection of the HIV reservoir in gut-associated viral sanctuaries, which might be used to evaluate any proposed eradication strategy., This substudy was supported by ViiV and the American Foundation for AIDS Research (amfAR) (ARCHE). IrsiCaixa was supported by the CERCA programme from Generalitat de Catalunya. MS was supported by the post-doctoral training scholarship (Juan de la Cierva) of the Spanish Economy and Competitiveness Ministry (FPDI-2013-17134). SM-L received a fellowship from the Agència de Gestió d’Ajuts Universitaris i de Recerca (2013FI_B 00275). CG was partially supported by the pre-doctoral fellowship of the Spanish Education, Culture and Sport Ministry (FPU15/03698). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sensitive quantification of the HIV-1 reservoir in gut-associated lymphoid tissue

  • Moron-Lopez, Sara|||0000-0003-0800-9205
  • Puertas, Maria C.|||0000-0002-6750-2318
  • Gálvez, Cristina|||0000-0002-2286-6193
  • Navarro, Jordi|||0000-0002-7187-0367
  • Carrasco-Rozas, Ana|||0000-0003-2165-8162
  • Esteve, Maria|||0000-0001-7716-0027
  • Manyè, Josep
  • Crespo Casal, Manuel|||0000-0001-9016-0515
  • Salgado, Maria|||0000-0003-1551-7216
  • Martinez Picado, Javier
Background. The implementation of successful strategies to achieve an HIV cure has become a priority in HIV research. However, the current location and size of HIV reservoirs is still unknown since there are limited tools to evaluate HIV latency in viral sanctuaries such as gut-associated lymphoid tissue (GALT). As reported in the so called "Boston Patients", despite undetectable levels of proviral HIV-1 DNA in blood and GALT, viral rebound happens in just few months after ART interruption. This fact might imply that current methods are not sensitive enough to detect residual reservoirs. Showing that, it is imperative to improve the detection and quantification of HIV-1 reservoir in tissue samples. Herein, we propose a novel nonenzymatic protocol for purification of Lamina Propria Leukocytes (LPL) from gut biopsies combined to viral HIV DNA (vDNA) quantification by droplet digital PCR (ddPCR) to improve the sensitivity and accuracy of viral reservoir measurements (LPL-vDNA assay). Methods. Endoscopic ileum biopsies were sampled from 12 HIV-1-infected cART- suppressed subjects. We performed a DTT/EDTA-based treatment for epithelial layer removal followed by non-enzymatic disruption of the tissue to obtain lamina propria cell suspension (LP). CD45+ cells were subsequently purified by flow sorting and vDNA was determined by ddPCR. Results. vDNA quantification levels were significantly higher in purified LPLs (CD45+) than in bulk LPs (p<0.01). The levels of vDNA were higher in ileum samples than in concurrent PBMC from the same individuals (p = 0.002). As a result of the increased sensitivity of thispurification method, the Poisson 95% confidence intervals of the vDNA quantification data from LPLs were narrower than that from bulk LPs. Of note, vDNA was unambiguously quantified above the detection limit in 100% of LPL samples, while only in 58% of bulk LPs. Conclusion. We propose an innovative combined protocol for a more sensitive detection of the HIV reservoir in gut-associated viral sanctuaries, which might be used to evaluate any proposed eradication strategy.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Switching From a Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen, A Randomized Clinical Trial to Determine the Effect on Peripheral Blood and Ileum Biopsies From Antiretroviral Therapy-suppressed Human Immunodeficiency Virus-infected Individuals

  • Moron-Lopez, Sara|||0000-0003-0800-9205
  • Navarro, Jordi|||0000-0002-7187-0367
  • Jimenez, Montse
  • Rutsaert, Sofie
  • Urrea, Víctor|||0000-0002-2577-856X
  • Puertas, Maria C.|||0000-0002-6750-2318
  • Torrella Domingo, Adriana|||0000-0003-1848-5096
  • De Clercq, Laura
  • Ribas, Bibiana Planas
  • Gálvez, Cristina|||0000-0002-2286-6193
  • Salgado, Maria|||0000-0003-1551-7216
  • Vandekerckhove, Linos|||0000-0002-8600-1631
  • Blanco, Julià|||0000-0002-2225-0217
  • Crespo Casal, Manuel|||0000-0001-9016-0515
  • Martínez Picado, Francisco Javier|||0000-0002-4916-2129
Optimization of combination antiretroviral therapy (cART) can impact the human immunodeficiency virus (HIV) reservoir. We evaluated the effect on the HIV reservoir in peripheral blood and ileum biopsies in patients switching from boosted protease inhibitor (PI/r)-based therapy to dolutegravir (DTG)-based therapy. Impact of Integrase-inhibitor DOlutegravir On the viral Reservoir (INDOOR) is a phase 4 open-label clinical trial that randomly included 42 HIV type 1-infected individuals on effective cART: 20 who switched from PI/r-based to DTG-based cART (switch group), and 22 who remained in PI/r-based regimens (control group). We analyzed blood and ileum biopsies to quantify episomal, total, and integrated HIV DNA, cell-associated HIV RNA, residual plasma viremia, T-cell subsets, cell activation, and inflammation markers. There were no related adverse events or treatment discontinuations due to drug intolerance. The HIV reservoir was consistently larger in ileal than in peripheral CD4 + T cells in both groups (P <.01). Residual viremia in plasma decreased in the switch group (P =.03). However, we did not observe significant longitudinal changes in low-level viral replication, total and integrated HIV reservoir, HIV transcription, T-cell maturation subsets, immunoactivation markers, inflammatory soluble proteins, or cellular markers of latently infected cells. The INDOOR study is the first evaluation of changes in HIV reservoir size in ileum biopsies and in peripheral blood in individuals switched from PI/r- to DTG-based cART. Although this switch was safe and well tolerated, it had no impact on a large array of immunological and inflammatory markers or on HIV reservoir markers in peripheral or in ileal CD4 + T cells. EudraCT 2014-004331-39. INDOOR evaluated the effect of switching from boosted protease inhibitor- to dolutegravir-based antiretroviral therapy on the HIV reservoir in peripheral blood and ileum. Residual plasma viremia and soluble CD14 levels decreased, but low-level HIV replication, the HIV reservoir, and immune activation remained unaffected.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Sensitive quantification of the HIV-1 reservoir in gut-associated lymphoid tissue

  • Morón-López, Sara
  • Puertas, Maria C.
  • Gálvez, Cristina
  • Navarro Mercadé, Jordi
  • Carrasco, Anna
  • Crespo Casal, Manuel
  • Esteve, Maria
Biòpsia; VIH-1; Teixit limfoide, Biopsia; VIH-1; Tejido linfoide, Biopsy; HIV-1; Lymphoid tissue, Background The implementation of successful strategies to achieve an HIV cure has become a priority in HIV research. However, the current location and size of HIV reservoirs is still unknown since there are limited tools to evaluate HIV latency in viral sanctuaries such as gut-associated lymphoid tissue (GALT). As reported in the so called “Boston Patients”, despite undetectable levels of proviral HIV-1 DNA in blood and GALT, viral rebound happens in just few months after ART interruption. This fact might imply that current methods are not sensitive enough to detect residual reservoirs. Showing that, it is imperative to improve the detection and quantification of HIV-1 reservoir in tissue samples. Herein, we propose a novel non-enzymatic protocol for purification of Lamina Propria Leukocytes (LPL) from gut biopsies combined to viral HIV DNA (vDNA) quantification by droplet digital PCR (ddPCR) to improve the sensitivity and accuracy of viral reservoir measurements (LPL-vDNA assay). Methods Endoscopic ileum biopsies were sampled from 12 HIV-1-infected cART-suppressed subjects. We performed a DTT/EDTA-based treatment for epithelial layer removal followed by non-enzymatic disruption of the tissue to obtain lamina propria cell suspension (LP). CD45+ cells were subsequently purified by flow sorting and vDNA was determined by ddPCR. Results vDNA quantification levels were significantly higher in purified LPLs (CD45+) than in bulk LPs (p<0.01). The levels of vDNA were higher in ileum samples than in concurrent PBMC from the same individuals (p = 0.002). As a result of the increased sensitivity of this purification method, the Poisson 95% confidence intervals of the vDNA quantification data from LPLs were narrower than that from bulk LPs. Of note, vDNA was unambiguously quantified above the detection limit in 100% of LPL samples, while only in 58% of bulk LPs. Conclusion We propose an innovative combined protocol for a more sensitive detection of the HIV reservoir in gut-associated viral sanctuaries, which might be used to evaluate any proposed eradication strategy., This substudy was supported by ViiV and the American Foundation for AIDS Research (amfAR) (ARCHE). IrsiCaixa was supported by the CERCA programme from Generalitat de Catalunya. MS was supported by the post-doctoral training scholarship (Juan de la Cierva) of the Spanish Economy and Competitiveness Ministry (FPDI-2013-17134). SM-L received a fellowship from the Agència de Gestió d’Ajuts Universitaris i de Recerca (2013FI_B 00275). CG was partially supported by the pre-doctoral fellowship of the Spanish Education, Culture and Sport Ministry (FPU15/03698). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.